3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
Details for Australian Patent Application No. 2005307744 (hide)
International Classifications
Event Publications
24 May 2007 PCT application entered the National Phase
PCT publication WO2006/055734 Priority application(s): WO2006/055734
9 June 2011 Application Accepted
Published as AU-B-2005307744
4 August 2011 Corrigenda
Applications Accepted - Name Index Under the name Arena Pharmaceuticals, Inc., Application No. 2005307744, Under INID (72), add co-inventor Choi, Jin Sun Karoline
24 November 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 14 Jul 2011
1 December 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005307746-And methods and apparatus for reading coded microbeads
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser